The Effects of Higher Protein Intake on Muscle Mass and Clinical Outcomes in Critically Ill Cancer Patients: A Prespecified Per-Protocol Analysis
Nutrients · 24.08.2025 · 17 (17) · 2742
DOI: 10.3390/nu17172742 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Nutrients, online erschienen am 24.08.2025. Verfasst von Jerusa Marcia Toloi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Anesthesiology, Postgraduate Program of Anesthesiology, Surgical Sciences and Perioperative Medicine, Faculty of Medicine, University of …. Hauptthemen laut MEDLINE: Critical Illness, Neoplasms, Dietary Proteins, Muscle, Skeletal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeicoamento de Pessoal de Nível Superior, Coordination for the Improvement of Higher Education Personnel (CAPES), the Ministry of Education (MEC) of Brazil.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background/Objectives: The optimal protein dose for critically ill cancer patients, especially for muscle mass preservation and survival, remains unclear. This study evaluated whether a higher protein intake, compared to usual intake, was associated with improved clinical outcomes in this population.
Methods
This was a prospective analysis of critically ill adult cancer patients admitted to an oncological intensive care unit (ICU). Patients were initially assigned to receive protein prescriptions of either 1.5 or 2.0 g per kilogram per day (g/kg/day), but due to common limitations in achieving prescribed targets in this setting, a prespecified per-protocol analysis was conducted. After three days of exclusive nutritional therapy, patients were reclassified into two groups based on actual protein intake: >1.5 g/kg/day (higher intake group, IG) and ≤1.5 g/kg/day (usual intake group, CG). The primary outcome was muscle mass preservation, measured by quadriceps muscle thickness (QMT) via ultrasound on days 1, 7, and 14. Secondary outcomes included ICU survival, hospital and ICU length of stay, mechanical ventilation duration, dialysis requirement, and 60-day survival.
Results
From June 2019 to September 2023, 117 patients were included. Following the planned interim analysis, the study was stopped after meeting the Pocock criterion for ICU survival (p = 0.0013). After reclassification, 68.4% (n = 80) were in the IG and 31.6% (n = 37) in the CG. ICU stay was similar (both medians 13 days), but the IG had shorter hospital stays [21.0 vs. 27.5 days, p = 0.020], less QMT loss, and improved ICU (HR = 0.31, 95% CI 0.15–0.64), hospital (HR = 0.43, CI 0.23–0.80), and 60-day survival (HR = 0.43, CI 0.23–0.80), along with shorter ventilation duration (HR = 0.54, CI 0.30–0.99).
Conclusions
Higher protein intake (>1.5 g/kg/day) was associated with better muscle mass preservation and improved clinical outcomes in critically ill cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Anesthesiology, Postgraduate Program of Anesthesiology, Surgical Sciences and Perioperative Medicine, Faculty of Medicine, University of São Paulo, Av. Dr. Arnaldo 455, Sao Paulo 05403-000, Brazil.
- Department of Nutrition, Barretos Cancer Hospital, R. Antenor Duarte Vilela 1331, Barretos 14784-400, Brazil.
- Department of Nutrition, Hospital Israelita Albert Einstein, Av. Albert Einstein, 627/701, Sao Paulo 05652-900, Brazil.
- Department of Anesthesiology, Perioperative and Pain Medicine, School of Medicine, Stanford University, Palo Alto, CA 94305, USA.
- Department of Critical Care, University Hospital of Universidad de la Republica (UDELAR), Av. Italia, Montevideo 11.600, Uruguay.
- Division of Critical Care, Department of Surgery, Ribeirão Preto Medical School, University of São Paulo, Av. Bandeirantes, 3900, Ribeirao Preto 14040-900, Brazil.
ORCID-Profile: Jerusa Marcia Toloi, Ana Carolina Gallo Laranja, Luiz Marcelo S Malbouisson, João Manoel Silva-Jr
Förderung
- Coordenação de Aperfeicoamento de Pessoal de Nível Superior
- Coordination for the Improvement of Higher Education Personnel (CAPES), the Ministry of Education (MEC) of Brazil
Zitieren
APA
Toloi, J. M., Laranja, A. C. G., Toledo, D. O., Treml, R. E., Malbouisson, L. M. S., Manzanares, W., & Silva-Jr, J. M. (2025). The Effects of Higher Protein Intake on Muscle Mass and Clinical Outcomes in Critically Ill Cancer Patients: A Prespecified Per-Protocol Analysis. Nutrients, 17(17), 2742. https://doi.org/10.3390/nu17172742
Vancouver
Toloi JM, Laranja ACG, Toledo DO, Treml RE, Malbouisson LMS, Manzanares W, et al. The Effects of Higher Protein Intake on Muscle Mass and Clinical Outcomes in Critically Ill Cancer Patients: A Prespecified Per-Protocol Analysis. Nutrients. 2025;17(17):2742. doi:10.3390/nu17172742
BibTeX
@article{Toloi2025,
author = {Toloi, Jerusa Marcia and Laranja, Ana Carolina Gallo and Toledo, Diogo Oliveira and Treml, Ricardo Esper and Malbouisson, Luiz Marcelo S and Manzanares, William and Silva-Jr, João Manoel},
title = {The Effects of Higher Protein Intake on Muscle Mass and Clinical Outcomes in Critically Ill Cancer Patients: A Prespecified Per-Protocol Analysis},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {17},
pages = {2742},
doi = {10.3390/nu17172742}
}
EUVIMED